Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions

Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions

0 Anmeldelser
0
Episode
406 of 2037
Længde
11M
Sprog
Engelsk
Format
Kategori
Fakta

Positive results from the first US Covid-19 trial raised investors’ hopes of an economic rebound, Chinese self-driving car start-ups have been accelerating pilot projects as US rivals sit idle, and bond investors have hit out at the growing trend of companies reporting “earnings before coronavirus”. Plus, the FT’s Kiran Stacey explains what the latest US sanctions against Huawei mean for the Chinese telecoms company’s survival.

To get free access to the FT’s Coronavirus Business Update newsletter for 30 days, visit ft.com/newsbriefingcovid or follow this link: https://www.ft.com/newsletter-signup/coronavirus?segmentId=9f398053-342f-c623-b5b3-1506d651696f.

Hosted on Acast. See acast.com/privacy for more information.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions

Other podcasts you might like ...